top of page
< Back

201905-117020

2019

Excellus

PPO

Gynecological

Pharmacy/ Prescription Drugs

Medical necessity

Overturned

Case Summary

Diagnosis: Obesity, Polycystic ovary syndrome
Treatment: Saxenda

Summary:
In this case the patient is a woman with a current BMI (body mass index) of 36.7 kg/m2 comorbid health conditions of PCOS (polycystic ovary syndrome). Initiation of Saxenda is medically necessary per FDA prescribing information and would be expected to be health beneficial for this patient in conjunction with a reduced calorie diet and exercise program.

bottom of page